Filing Flows › Crescent Biopharma (CBIO) › How it makes money
How Crescent Biopharma (CBIO) makes money
Crescent Biopharma (CBIO) made $1.0M of revenue in the first quarter 2026 (Q1 2026).
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q1 2026 | % of revenue |
|---|---|---|
| Revenue | $1.0M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q1 2026 | $1.0M | — |
From Crescent Biopharma's 10-Q filed Apr 29, 2026 (on EDGAR).
Questions
How does Crescent Biopharma make money?
Crescent Biopharma (CBIO) made $1.0M of revenue in the first quarter 2026 (Q1 2026).
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.